Douglas E. Williams, EVP Research & Development at BIOGEN INC. (BIIB), sold 3,841 shares at $410.00 ($1.6M) on 2015-06-19, disclosed to the SEC on 2015-06-22.
Scheduled sale ($1.6M) by EVP Research & Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CDAK | SELL | 2023-01-23 | $3K | — | Filing → |
| OVID | BUY | 2018-08-16 | $32K | — | Filing → |
| BIIB | SELL | 2014-03-21 | $1.2M | — | Filing → |